Conversely, the clinical reliability of methods, such as ELISpot [43] or QuantiFERON [44] determining HCMV-specific CD8+ T-cells only, appears questionable in view of these data for precise clinical immunologic monitoring of HCMV infection in transplant recipients. Here, CD8A is linked to cytomegalovirus infection.